SARAJEVO (Bosnia and Herzegovina), June 26 (SeeNews) – Bosnian drug maker Bosnalijek said on Tuesday its shareholders approved a dividend of 0.52 marka ($0.31/0.27 euro) per share for 2017, up slightly from 0.5 marka a year earlier.